SCHEMBL31446878

SCHEMBL31446878

Cc1cc2c(O)c(C(=O)O)cnc2c(C2CC2)n1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ POLB P06746 2/20 0.39
▸ KDM4E B2RXH2 5/20 0.38
▸ KMT2A Q03164 1/20 0.38
▸ MAPT P10636 2/20 0.36
▸ GABRP O00591 1/20 0.35
▸ GABRD O14764 1/20 0.35
▸ GABRA1 P14867 1/20 0.35
▸ GABRB1 P18505 1/20 0.35
▸ GABRG2 P18507 1/20 0.35
▸ GABRB3 P28472 1/20 0.35
▸ GABRA5 P31644 1/20 0.35
▸ GABRA3 P34903 1/20 0.35
▸ GABRA2 P47869 1/20 0.35
▸ GABRB2 P47870 1/20 0.35
▸ GABRA4 P48169 1/20 0.35
▸ GABRE P78334 1/20 0.35
▸ GABRA6 Q16445 1/20 0.35
▸ GABRG1 Q8N1C3 1/20 0.35
▸ GABRG3 Q99928 1/20 0.35
▸ GABRQ Q9UN88 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31446898 0.84 KDM4E (0.42) KDM4EKMT2AMAPTALDH1A1HPGD
SCHEMBL31447152 0.79 SLC2A1 (0.36) KDM4EKMT2ACHRM4HSD11B1
SCHEMBL1015670 0.70 HSD11B1 (0.50) POLBKDM4EKMT2AMAPTGABRP
SCHEMBL31447231 0.70 KMT2A (0.33) POLBKDM4EKMT2AMAPTALDH1A1
SCHEMBL6197857 0.69 KDM4E (0.39) KDM4EGABRPGABRDGABRA1GABRB1
SCHEMBL732403 0.69 DHODH (0.44) KDM4EKMT2AGABRPGABRDGABRA1
SCHEMBL5025887 0.69 GABRP (0.41) POLBKDM4EKMT2AMAPTGABRP
SCHEMBL3822431 0.65 POLB (0.37) POLBKDM4EKMT2AMAPTGABRP
SCHEMBL6199950 0.65 KDM4E (0.41) KDM4EKMT2AGABRPGABRDGABRA1
SCHEMBL6201203 0.65 KDM4E (0.41) KDM4EKMT2AMAPTGABRPGABRD

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025072265-A1 SOMATOSTATIN SUBTYPE RECEPTOR 3 (SSTR3) AGONISTS AND USES THEREOF Crinetics Pharmaceuticals, Inc. (US) 2025-04-03 — — WO disclosed
Send feedback